| Literature DB >> 26259941 |
Mark L Wilson, Donald J Krogstad, Emmanuel Arinaitwe, Myriam Arevalo-Herrera, Laura Chery, Marcelo U Ferreira, Daouda Ndiaye, Don P Mathanga, Alex Eapen.
Abstract
A major public health question is whether urbanization will transform malaria from a rural to an urban disease. However, differences about definitions of urban settings, urban malaria, and whether malaria control should differ between rural and urban areas complicate both the analysis of available data and the development of intervention strategies. This report examines the approach of the International Centers of Excellence for Malaria Research (ICEMR) to urban malaria in Brazil, Colombia, India (Chennai and Goa), Malawi, Senegal, and Uganda. Its major theme is the need to determine whether cases diagnosed in urban areas were imported from surrounding rural areas or resulted from transmission within the urban area. If infections are being acquired within urban areas, malaria control measures must be targeted within those urban areas to be effective. Conversely, if malaria cases are being imported from rural areas, control measures must be directed at vectors, breeding sites, and infected humans in those rural areas. Similar interventions must be directed differently if infections were acquired within urban areas. The hypothesis underlying the ICEMR approach to urban malaria is that optimal control of urban malaria depends on accurate epidemiologic and entomologic information about transmission. © The American Society of Tropical Medicine and Hygiene.Entities:
Mesh:
Year: 2015 PMID: 26259941 PMCID: PMC4574269 DOI: 10.4269/ajtmh.14-0834
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Figure 1.Locations of the International Centers of Excellence for Malaria Research (ICEMR) sites, including the seven sites reporting studies on urban malaria.
Types of evidence used to infer whether urban malaria is the result of transmission in an urban setting
| Strength of evidence | Human surveillance | Human surveillance metrics | Entomological surveillance | Entomological indices | Parasite or vector genetic analysis |
|---|---|---|---|---|---|
| Weakest | Febrile disease at urban clinic | – | – | – | Parasite count (no. per microliter blood) |
| Slide or PCR confirmed diagnosis at urban clinic | PP of humans that are thick smear positive | Nearby presumed breeding sites | – | Infected humans: MOI from MSP1 genotyping, molecular barcodes, microsatellites, whole genome sequencing, SNP arrays | |
| Confirmed infection in UR | Incidence of laboratory confirmed malaria ( | CV larvae/pupae in breeding site ( | – | – | |
| More infection in permanent URs than in travelers | PP higher in “urban” than “rural” setting; PP higher in permanent URs than travelers | CV adults in houses (vector density/immature density); cohabitation with other vectors in breeding sites | Human blood meal index (% blood-fed and ELISA positive) | Malaria parasites: frequencies of drug resistance markers such as | |
| – | Higher incidence ( | Blood-fed CV adults resting inside house (may be endophilic or exophilic) | HBR | – | |
| Greater PP prevalence among non-travelers | Greater PP among “non-travelers” | Sporozoite-infected adult mosquitoes | SP (% of CSP-positive adult female CVs) | – | |
| – | – | HLC or bednet trapping of CV ( | EIR estimate | Anopheline vectors: markers for M and S chromosomal forms, PCR for species confirmation, drug resistance markers ( | |
| Strongest | Confirmed | ACD of elevated PP among sick and healthy people lacking travel history | Blood-fed gametocyte-infected adult mosquitoes and breeding sites nearby household | Peri-domestic breeding site(s) + sporozoite-infected adult mosquitoes + CSP-positive CVs | Similar or identical parasite clones in anopheline vectors and humans from same urban settings |
ACD = active case detection; CSP = circumsporozoite protein; CV = competent vector species; EIR = entomological inoculation rate (infective bites/person/year); ELISA = enzyme-linked immunosorbent assay; HBR = human biting rate; HH = household(s); MOI = multiplicity or clonality of infection; MSP1 = merozoite surface protein-1; PCR = polymerase chain reaction; PP = parasite prevalence in humans; SNP = single nucleotide polymorphism; SP = sporozoite prevalence; UR = urban resident(s).
The strength of evidence for Plasmodium parasites, Anopheles vectors, and relationships with humans is ranked from weakest to strongest with regard to implicating local urban transmission.
Summary of the geographic, demographic, and climatic characteristics of each of the seven ICEMR sites that are studying malaria in urban settings
| ICEMR (urban site, region, country) | Amazonia (Mâncio Lima City, Acre State, Brazil) | East Africa (Jinja City, Jinja District, Uganda) | India (Besant Nagar, Chennai City Tamil Nadu State, India) | Latin America (Quibdó City, Chocó Department, Colombia) | Malawi (Communities in Blantyre City, Malawi) | South Asia (Panaji City, Goa State, India) | West Africa (Madina Fall, Thiès City, Thiès Region, Senegal) |
|---|---|---|---|---|---|---|---|
| Latitude/longitude | 7.62° S, 72.89° W | 0.45° N, 33.24° E | 13.00° N, 80.27° E | 5.69° N, 76.66° W | 15.67° S, 34.97° E | 15.50° N, 73.83° E | 14.83° N, 16.92° E |
| Elevation (m) | 200 | 1,140 | 6 | 30 | 766 | 7 | 60 |
| Area (km2) | 5,453 | 12,853 | ∼21 | 3,338 (6,078) | 228 | 36 | 2.47 |
| Population | 16,795 | 31,900 | 4.7 M | 120,000 | 1.01 M | 114,405 | 320,000; 21,000 Madina Fall |
| Population density | 2.79/km2 | 2.5/km2 | 10,988/km2; 0.2 M Besant Nagar | 362,625; 36.0 (59.7)/km2 | 4,400/km2 | 3,177/km2 | 8,502/km2 |
| Climate | Dry: July–September | Wet: March–May and September–November | Tropical monsoon | Transmission throughout year | Tropical highland | Hot humid: March–May | Sudan–Savanna |
| Seasonality | Wet: October–June | Dry: December–February and June–August | Hot dry (March–June); Hot Wet (Oct–Dec) | Mild dry (May–September); Hot wet (October–April), | Monsoon: June–September; Winter: December–February | Mild dry (January–June), Hot wet (July–November) | |
| Rainfall (mm) | 2,200 | 1,334 | ∼1,400 | 8,131 (≥ 500/month) | 1,127 | 2,932 | 438 |
| Mean temperature (°C) | 27 | 23 | 33 | 27 | 22 | 27 | 24 |
| Estimates of prevalence, intensity of transmission | Prevalence: | Prevalence = 8.8% (7.5–10.2%); Incidence = 0.48 (0.42–0.55) PPY | Prevalence = 18.6% (2014); 77% prevalence decline at Besant Nagar (2011–2014) | Prevalence: | Year-round transmission; slide prevalences: ∼5% (dry season), ∼8% (rainy season) | Slide prevalence: | Prevalence < 1%, incidence uncomp-mal ≤ 1.1 × 10−3/month, 1,000–2,000 dx/year at referral clinic |
| EIR = unknown | EIR = 2.8 (1.6–4.5) PPY | EIR = unknown | EIR = unknown | EIR = unknown | EIR = 2.35 PPY | EIR = 0.0 PPY, 0.0% vectors CSP positive | |
| Aims, questions, hypotheses | Determine if in active/abandoned aquaculture produces vector breeding sites that facilitates urban transmission | XS and entomological surveys, longitudinal cohort, capacity building, technology transfer, research-policy maker links | Evaluate vector transmission, drug resistance, sexual/asexual infection, mixed species/strains, diversity of | Identify epidemiologic and other factors responsible for transmission | Evaluate risk factors in urban vs. rural children; HH risk for infection, asymptomatic gametocytemia and anemia | Examine parasite genetics; resistance and immunity; infection prevalence; vector identification | Obtain prevalence from XS surveys, then focus on urban areas with potential breeding sites |
| Site-specific references |
CSP = circumsporozoite surface protein; EIR = entomological inoculation rate (infectious bites PPY); HH = household; ICEMR = International Centers of Excellence for Malaria Research; M = million; Pv = Plasmodium vivax; Pf = Plasmodium falciparum; PPY = per person per year; XS = cross-sectional.
Summary of the study design, questions, methods, human sampling, and analytical characteristics of each of the seven ICEMR sites conducting research on malaria in urban settings
| ICEMR (urban site, region, country) | Amazonia (Mâncio Lima City, Acre State, Brazil) | East Africa (Jinja City, Jinja District, Uganda) | India (Besant Nagar, Chennai City Tamil Nadu State, India) | Latin America (Quibdó City, Chocó Department, Colombia) | Malawi (Communities in Blantyre City, Blantyre District Malawi) | South Asia (Panaji City, Goa State, India) | West Africa (Madina Fall, Thiès City, Thiès Region, Senegal) |
|---|---|---|---|---|---|---|---|
| Types of epidemiologic studies | Prospective, observational | Incidence and prevalence surveillance | Epidemiologic, experimental, and laboratory-based genetic studies | Descriptive epidemiologic surveillance | Ecologic, environmental and laboratory based | Epidemiologic, experimental, and laboratory based | Community-based longitudinal cohort study |
| Outcome(s) being measured | Time/GIS pattern by genotype; clonal expansion; vector breeding sites; larval genetic markers to estimate migration | Infection incidence (0.55–0.36/year); prevalance (9.8–6.7%); EIR 4.0–1.8; prevalence of anemia | Prevalance of infection; MOI; genetic diversity of | Prevalance and origin of infection (local or imported); vector presence and predominance; human–vector contact | Urban vs. rural behavioral, SES, environmental risk | MOI, disease severity, genetic variation, drug resistance, | Infection duration and prevalence; antibodies to vaccine antigens (in study cohort); home visits to evaluate/review symptoms |
| Prevalence of parasitemia (including gametocytemia) in healthy subjects | |||||||
| Exposure(s) or predictor(s) being measured | Environmental: breeding sites; behavior: travel to rural sites and other malaria-endemic areas | LLINs, HH structure, vegetation, temperature, and humidity | Environmental micro-climate, temperature, and humidity (larval and adult vector studies); vector saliva antibodies | Humidity, rainfall, temperature, breeding sites, vector contact by antibodies to vector saliva | Housing, vector proximity, prevention methods | Geographic (migration, travel history), occupational (i.e., migrants, construction workers) | Intensity of vector-to-human transmission; vector breeding sites (GIS) |
| Demographic, pregnancy, season | |||||||
| Study designs being used | PID at government HF | Longitudinal cohort | XS surveys (ACD, and RCD); PCD at clinic and longitudinal cohort designs | XS studies (ACD, RCD) and interventions | Case–control HF + follow-up | PCD at tertiary care government hospital | Cross-sectional, household-based prospective study design |
| Community XS/school surveys | XS, HH-based designs | ||||||
| Sources of subjects | Government HFs | Community HHs | Community HHs | HHs, HFs | HFs, HHs | HFs | Community HHs |
| Community HHs | |||||||
| Selection or sampling method of subjects | Persons seeking malaria diagnosis and treatment at government HFs | Sample of 100 HHs with children + caregiver > 18 | Epidemiologic study (random sampling); environmental based (transmission study) | Recruitment of cases at HFs | Any visitor to HF fitting the inclusion criteria | Positives at HFs | Random sample of HHs initially |
| Sample of 200 HHs + three schools | Active case detection at two sites with 900 people per site | All HH members | |||||
| Definition and determination of urban | Households are considered urban if residents call them urbano | Not predefined | Based on current guidelines from the MoH (UMS of India) and the city of Chennai for the community of Besant Nagar | Urban as defined by a government; examine effects of sociodemographic and geographic factors (including GIS) | Government city limits; multiple definitions and criteria | Defined by Indian government administrative criterion, including agglomerations | City population of 320,000 with 1,000–2,000 |
| Random HHs in city | |||||||
| Age(s) of subject(s) | Persons of all ages | 6 months–11 years | ≤ 1 to ≤ 70 year old (Eco-Epidemiology Project) | > 2 year old | ≤ 15 years old | Subjects ≤ 1–65 years old | Persons of all ages |
| Person > 18 years old | All ages | ||||||
| Sample period | January 2015–January 2016 | August 2011–present | XS: December 2013–December 2014 | June 2014 (pilot) | April 2012–present | Apr 2012–present | September 2012–present |
| Clin: 2013–present | April 2012–present | ||||||
| RCD: 2014–present | |||||||
| Mosq: 2013–2014 | |||||||
| Long: February 2013–January 2014 | |||||||
| Sample frequency | 5 days/week (Monday–Friday) when HFs open | During illness and at 3 months checkup | Clin, RCD: ∼weekly; XS: quarterly, Long: monthly | Twice yearly | All year, 5 days/week | Daily (one time-point per subject) | Twice yearly XS surveys |
| 6 weeks × 2/year | |||||||
| Contextual information or confounders | To be defined | Socioeconomic status, housing | Travel (as a potential confounding factor) | KAP surveys, case investigations (for travel and occupational histories) | KAP, SES, travel (confounders) | Travel, clinical presentation, previous antimalarial treatment | HH conditions (contextual); preventive measures (confounder) |
| SES, prevention, ITN, IPTp, location (confounders) | |||||||
| Unit(s) of analysis | Individual people; HHs parasite: clones breeding sites | Individual people; HHs | Individual people census clusters (XS surveys) | Individuals, HHs, study sites | Individual people, HH, HF, urban–rural environments | Individual people: parasite isolates/clones; vectors at construction sites | Individual people (longitudinal cohort studies), HHs (XS surveys), communities |
| Individual people, HH, EA | |||||||
| Analytical approaches being used | Spatial analysis: human infection genotype clusters near breeding sites | Statistical, modeling and spatial analysis | Spatial analysis; time series | Descriptive and inferential statistics. spatial analysis and statistical modeling | Logistic regression, multilevel, spatial | ICEMR analyses are specialized for each biological question | Initially descriptive, hypotheses based on seasonality, spatial clustering |
| Regression, multilevel statistic |
ACD = active case detection; EA = Enumeration Area; GIS = geographic information system; HBI = human biting index; HF = health facility; HH = household; IPTp = intermittent preventive treatment in pregnancy; ITN = insecticide-treated net; KAP = knowledge, attitudes and practices; LLINs = long-lasting insecticidal nets; MoH = Ministry of Health; MOI = multiplicity of infection; ICEMR = International Centers of Excellence for Malaria Research; PCD = passive case detection; PID = passive infection detection; Pv = Plasmodium vivax; Pf = Plasmodium falciparum; RBC = red blood cell; RCD = reactive case detection; SES = socioeconomic status; UMS = Urban Malaria Scheme; XS = cross-sectional.
Summary of the Plasmodium and Anopheles species present, vector sampling, and laboratory methods at each of the seven ICEMR sites that are investigating malaria in urban settings
| ICEMR (urban site, region, country) | Amazonia (Mâncio Lima City, Acre State, Brazil) | East Africa (Jinja City, Jinja District, Uganda) | India (Besant Nagar, Chennai City, Tamil Nadu State, India) | Latin America (Quibdó City, Chocó Department, Colombia) | Malawi (Communities in Blantyre City, Blantyre District, Malawi) | South Asia (Panaji City, Goa State, India) | West Africa (Madina Fall, Thiès City, Thiès Region, Senegal) |
|---|---|---|---|---|---|---|---|
| Vector sampling | Larvae: dipping | Larvae: dipping | Larvae: dipping | Adults: HLC | Larvae: dipping (outdoor ground) | Adults: CDC light traps in sleeping areas of construction sites | Adults: HLC for biting rates, EIRs |
| Adults: CDC light traps | Adult HLC and PSC for biting rates, EIR | Transects from rural to peri-urban and to urban areas | Adults: light traps | PSCs likewise for biting rates, EIRs | |||
| Vector testing | ID: morphology, planned: PCR | ID: morphology, PCR | ID: morphology for spp., egg ridge for races or ecological variation | ID: morphology, PCR | ID: morphology, PCR for species | ID: morphology, PCR | ID: PCR |
| Blood meal: PCR | Infection: sporozoite CSP by ELISA | Blood meal for host | Infection: sporozoite CSP by ELISA | Infection: sporozoite CSP by ELISA | Genotype: PCR | Infection: sporozoite CSP ELISA | |
| Infection: sporozoite PCR | Infection: sporozoite CSP by ELISA | Blood meal: PCR | Blood meal: ELISA | ||||
| Laboratory and field testing | Humans: smears, PCR, nested PCR | Humans: RDT, thick smear microscopy, Hemocue for Hb, immunologic studies | Humans: RDT, Hemocue for Hb | Humans: thick smear, RDT | Humans: slide microscopy, RDT | Humans: RDT, thick and thin smear, PCR, qPCR, sequencing, flow cytometry | Humans: RDT |
| Parasite typing based on SNPs or microsatellites | Laboratory: thick and thin smear and PCR | Laboratory: PCR-based parasite species ID | Laboratory: qRT-PCR | Laboratory: thick smear or PCR for diagnosis of human infection |
CDC = Centers for Disease Control and Prevention; CSP = circumsporozoite surface protein; EIR = entomologic inoculation rate; ELISA = enzyme-linked immunosorbent assay; Hb = hemoglobin; HF = health facility; HLC = human landing catches; ICEMR = International Centers of Excellence for Malaria Research; PSC = pyrethroid spray capture; qRT-PCR = quantitative reverse transcription polymerase chain reaction; RDT = rapid diagnostic test; SNP = single nucleotide polymorphism test.
Research questions of common interest across the ICEMR network at urban sites in South America, Asia, and sub-Saharan Africa
| Evaluation of malaria in urban areas | Malaria in urban areas ranges from foci of intense transmission to obvious importations in travelers returning from highly endemic areas |
| Because the intensity of transmission is typically lower in urban than rural areas, proof of urban malaria transmission is uncommon | |
| This inadvertently means that the term “urban malaria” is often applied empirically to all persons whose malaria was diagnosed in urban areas | |
| Although difficult, the proof of transmission (or the lack of transmission) in urban areas is an essential priority for malarial control | |
| This is because proof of transmission simultaneously provides both new information and potential malaria control strategies | |
| Descriptive epidemiology | What are the age distributions of malarial infection (parasitemia, positive smears) and disease (uncomplicated and complicated/severe malaria)? |
| Is there evidence that children, adults, or others are protected from (or at increased risk of) infection or disease? | |
| Seasonality | Does the prevalence of infection (parasitemia) decrease during the dry season and increase with the return of seasonal rains? |
| How are seasonal patterns such as rainfall related to the incidence of disease? | |
| When does the incidence of malarial disease peak in relation to the intensity of transmission and the peak prevalence of infection? | |
| Length of residence | The effects of prolonged residence in this or other malaria-endemic areas |
| Do persons who have lived in this or other malaria-endemic areas for ≥ 10 years acquire either the semi-immune state (protection against serious disease) or sterile immunity (protection against both infection and disease)? | |
| Entomologic factors | What vectors are present at different study sites during the different times (seasons) of the year? |
| How do their biting rates and EIRs relate to the frequency of human infection and disease? | |
| Are these characteristics in more urban settings similar to or different from what has been found in rural areas? | |
| Complex malaria | Why are infections with more than one parasite genotype most common with |
| Conversely, why are infections with more than one parasite species (e.g., | |
| Why are |
EIRs = entomologic inoculation rates; ICEMR = International Centers of Excellence for Malaria Research.